Performance tests

Environmental Health Perspectives
A Wetherell

Abstract

This paper discusses the use of psychological performance tests to assess the effects of environmental stressors. The large number and the variety of performance tests are illustrated, and the differences between performance tests and other psychological tests are described in terms of their design, construction, use, and purpose. The stressor emphasis is on the effects of drugs since that is where most performance tests have found their main application, although other stressors, e.g., fatigue, toxic chemicals, are mentioned where appropriate. Diazepam is used as an example. There is no particular performance emphasis since the tests are intended to have wide applicability. However, vehicle-driving performance is discussed because it has been the subject of a great deal of research and is probably one of the most important areas of application. Performance tests are discussed in terms of the four main underlying models--factor analysis, general information processing, multiple resource and strategy models, and processing-stage models--and in terms of their psychometric properties--sensitivity, reliability, and content, criterion, construct, and face validity. Some test taxonomies are presented. Standardization is also discusse...Continue Reading

References

Apr 1, 1975·British Journal of Clinical Pharmacology·A J Bond, M H Lader
Feb 1, 1977·British Journal of Clinical Pharmacology·K A George, J W Dundee
Mar 23, 1977·Psychopharmacology·N C Moore
Oct 1, 1977·British Journal of Clinical Pharmacology·I HindmarchA J Hewett
Jan 1, 1979·British Journal of Clinical Pharmacology·J R Wittenborn
Jan 1, 1979·British Journal of Clinical Pharmacology·J R WittenbornR J Nash
Mar 28, 1979·Psychopharmacology·M W Church, L C Johnson
Jan 1, 1979·Psychopharmacology·S E File, A J Bond
Feb 1, 1978·Electroencephalography and Clinical Neurophysiology·N Adam, G I Collins
Oct 1, 1979·Electroencephalography and Clinical Neurophysiology·J M FordB S Kopell
Jan 1, 1975·Journal of Studies on Alcohol·R H Klein, H R Jex
Jan 1, 1975·Psychopharmacologia·I Dureman, B Norrman
Apr 1, 1978·Oral Surgery, Oral Medicine, and Oral Pathology·S A CooperG O Kruger
Jan 1, 1977·British Journal of Clinical Pharmacology·J R Wittenborn
Oct 1, 1978·British Journal of Clinical Pharmacology·C H Clarke, A N Nicholson
Oct 1, 1979·Acta Pharmacologica Et Toxicologica·E S PalvaM J Mattila
Mar 23, 1977·Psychopharmacology·M M Ghoneim, S P Mewaldt
May 1, 1979·British Journal of Clinical Pharmacology·D M JonesT L Spriggs
Dec 1, 1977·Perceptual and Motor Skills·H B Orenstein, K M Hamilton
Feb 1, 1978·Human Factors·C J ColbournA K Copeman
Mar 1, 1978·Ergonomics·L Bainbridge
Jun 1, 1978·Perceptual and Motor Skills·O H RundellB K Lester
Oct 1, 1978·British Journal of Clinical Pharmacology·D M JonesT L Spriggs
Jan 1, 1978·Neuropsychologia·K McFarland, R Ashton
Jan 1, 1976·Annals of the New York Academy of Sciences·R W HansteenB Jones
Jun 23, 1976·Psychopharmacology·J R WittenbornW E McGough
Sep 29, 1976·Psychopharmacology·S J Dimond, E M Brouwers
Dec 21, 1976·Psychopharmacology·K L DavisK Train
Apr 1, 1977·Human Factors·A B Dott, R K Mckelvy
Apr 1, 1977·British Journal of Clinical Pharmacology·A W PeckR Claridge
Aug 1, 1977·Journal of Experimental Psychology. Human Perception and Performance·J R PomerantzR J Stoever
Jun 1, 1977·British Journal of Clinical Pharmacology·C H Clarke, A N Nicholson
Oct 1, 1976·Anesthesiology·M J FruminM E Jarvik
Apr 1, 1976·British Journal of Clinical Pharmacology·J HartA W Peck

❮ Previous
Next ❯

Citations

Apr 1, 1996·Environmental Health Perspectives·N FiedlerA Wetherell
Nov 13, 2008·International Archives of Occupational and Environmental Health·Stephan SandrockBarbara Griefahn
Aug 13, 2005·Disability and Rehabilitation·Veli Matti Heikkilä, Tapani Kallanranta
May 21, 2008·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·James P Zacny, Sandra Gutierrez
Sep 3, 2011·The British Journal of Social Psychology·Margaret Wetherell
Aug 22, 2013·British Journal of Clinical Pharmacology·Leonie MantheyFrans G Zitman
May 26, 2004·Pharmacology, Biochemistry, and Behavior·Sandra GutierrezJames P Zacny
Aug 11, 2004·Pharmacology, Biochemistry, and Behavior·James P Zacny, Nancy J Beckman
Feb 21, 2008·Nutritional Neuroscience·Harris R Lieberman
Sep 3, 2011·Pharmacology, Biochemistry, and Behavior·James P ZacnyDennis W Coalson
Jul 27, 2015·International Journal of Epidemiology·Rikke LundMerete Osler
Sep 25, 2019·Perceptual and Motor Skills·Jingyun ShenZhiwei Lian
Aug 17, 2006·Nutrition Reviews·Harris R Lieberman

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.